Modern Care Journal

Published by: Kowsar

Assessing the Hepatitis C Genotype in Prisoners Infected with HCV in South Khorasan- 2014

Zohreh Azarkar 1 , * , Gholamreza Sharifzadeh 1 and Mohammad Fereidouni 2
Authors Information
1 Infectious Disease Researches Center, Birjand University of Medical Sciences, Birjand, IR Iran
2 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
Article information
  • Modern Care Journal: April 2018, 15 (2); e63680
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: November 14, 2017
  • Revised: January 10, 2018
  • Accepted: April 10, 2018
  • DOI: 10.5812/modernc.63680

To Cite: Azarkar Z, Sharifzadeh G, Fereidouni M. Assessing the Hepatitis C Genotype in Prisoners Infected with HCV in South Khorasan- 2014, Mod Care J. 2018 ; 15(2):e63680. doi: 10.5812/modernc.63680.

Copyright © 2018, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Simmonds P. Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol. 2004;85(Pt 11):3173-88. doi: 10.1099/vir.0.80401-0. [PubMed: 15483230].
  • 2. Poynard T, Ratziu V, Benhamou Y, Opolon P, Cacoub P, Bedossa P. Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(2):211-28. [PubMed: 10890317].
  • 3. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007;37(2):101-3. doi: 10.1111/j.1872-034X.2007.00015.x. [PubMed: 17300704].
  • 4. Joukar F, Khalesi AK, Jafarshad R, Rahimabadi MS, Mansour-Ghanaei F. Distribution of hepatitis C virus genotypes in haemodialysis patients of Guilan, northern Islamic Republic of Iran. East Mediterr Health J. 2012;18(3):236-40. [PubMed: 22574476].
  • 5. Jimenez-Mendez R, Uribe-Salas F, Lopez-Guillen P, Cisneros-Garza L, Castaneda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol. 2010;9(1):33-9. [PubMed: 20308720].
  • 6. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther. 2005;10(1):1-11. [PubMed: 15751759].
  • 7. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558-67. doi: 10.1016/S1473-3099(05)70216-4. [PubMed: 16122679].
  • 8. Grimaldi E, Della Pepa ME, Martora F, Magliocca P, Iovene MR, Coppola N, et al. Distribution of Hepatitis C Virus Genotypes and Subtypes in the Metropolitan Area of Naples, Italy, in the Era of Interferon-Free Regimens. Intervirology. 2017;60(3):82-9. doi: 10.1159/000481821. [PubMed: 29161710].
  • 9. Acero Fernandez D, Ferri Iglesias MJ, Buxo Pujolras M, Lopez Nunez C, Serra Matamala I, Queralt Moles X, et al. Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years. Gastroenterol Hepatol. 2018;41(1):2-11. doi: 10.1016/j.gastrohep.2017.09.004. [PubMed: 29150360].
  • 10. Ray S, Thomas DL. Hepatitis C. In: Mandell GL, Bennet J, Dolin R, editors. Principle and practice of infectious disease. Philadelphia: Elsevier-churcilllivingstone; 2015. p. 1908-27.
  • 11. Vahdat K, Amini A, Motamed N, Eghbali SS, Zandi K, Hajiani G. Determination of Hepatit C genotype and risk factors of transmission in Bushehr province 2008. Tibb-i junub. 2012;15(1):51-8.
  • 12. Haghshenas MR, Babamahmoodi F, Rafiei AR, Vahedi V. The Correlation between HCV Genotypes and Liver Damage in HCV Patients. J Mazandaran Univ Med Sci. 2011;21(85):76-83.
  • 13. Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic analysis of hepatitis C virus in khuzestan province, southwestern iran. Middle East J Dig Dis. 2011;3(2):126-30. [PubMed: 25197544]. [PubMed Central: PMC4154916].
  • 14. Azarkar Z, Sharifzadeh G. Evaluation of the prevalence of hepatitis B, hepatitis C, and HIV in inmates with drug-related convictions in Birjand, Iran in 2008. Hepat Mon. 2010;10(1):26.
  • 15. Ebrahimzadeh A, Azarkar Z, Ziaee M, Sharifzadeh G, Bijari B. Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014. Int J Infect. 2016;3(1). doi: 10.17795/iji-34102.
  • 16. Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, et al. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology. 2003;37(3):600-9. doi: 10.1053/jhep.2003.50106. [PubMed: 12601358].
  • 17. Martinot-Peignoux M, Ripault MP, Maylin S, Boyer N, Giuily N, Castelnau C, et al. [618] optimal pretreatment viral load cut-off to predict treatment outcome in patients with chronic hepatitis c treated with peginterferon o-2b plus ribavirin. J Hepatol. 2007;46. S234. doi: 10.1016/s0168-8278(07)62216-8.
  • 18. Zeuzem S, Fried MW, Reddy RK, Marcellin P, Diago M, Craxi A, et al. Improving the clinical relevance of pre-treatment viral load as a predictor of sustained virological response (SVR) in patients infected with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD)(PEGASYS®) plus ribavirin (COPEGUS®). Hepatology. 2006;44:267A-8A.
  • 19. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, et al. Hepatitis C in asymptomatic blood donors. Hepatology. 1997;26(3 Suppl 1):29S-33S. doi: 10.1002/hep.510260705. [PubMed: 9305660].
  • 20. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology. 2000;32(3):582-7. doi: 10.1053/jhep.2000.9714. [PubMed: 10960453].
  • 21. Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999;341(12):866-70. doi: 10.1056/NEJM199909163411202. [PubMed: 10498458].
  • 22. Vossughinia H, Goshayeshi L, Bayegi HR, Sima H, Kazemi A, Erfani S, et al. Prevalence of hepatitis C virus genotypes in mashhad, northeast iran. Iran J Public Health. 2012;41(9):56-61. [PubMed: 23193507]. [PubMed Central: PMC3494216].
  • 23. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, et al. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig Dis Sci. 2006;51(8):1420-5. doi: 10.1007/s10620-005-9025-9. [PubMed: 16868830].
  • 24. Bozdayi G, Rota S, Verdi H, Derici U, Sindel S, Bali M, et al. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution]. Mikrobiyol Bul. 2002;36(3-4):291-300. Turkish. [PubMed: 12838663].
  • 25. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol. 2006;5:4. doi: 10.1186/1476-5926-5-4. [PubMed: 17014721]. [PubMed Central: PMC1599752].
  • 26. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi J Kidney Dis Transpl. 2008;19(3):461-5. [PubMed: 18445914].
  • 27. Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis. 2008;12(3):239-44. doi: 10.1016/j.ijid.2007.07.003. [PubMed: 17942359].
  • 28. Turkoglu S, Bozaci M, Bozfakioglu S, Kaymakoglu S, Badur S. Molecular epidemiology of hepatitis C virus in Istanbul, Turkey. J Microbiol Methods. 1996;27(1):98. doi: 10.1016/0167-7012(96)83736-5.
  • 29. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. [PubMed: 25086286].
  • 30. Tyczyno M, Halota W, Nowak W, Pawlowska M. Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz. Hepat Mon. 2014;14(5). e14559. doi: 10.5812/hepatmon.14559. [PubMed: 24910703]. [PubMed Central: PMC4030260].
  • 31. Samimi-Rad K, Hosseini M, Mobeini G, Asgari F, Alavian SM, Tahaei ME, et al. Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran. East Mediterr Health J. 2012;18(3):227-35. [PubMed: 22574475].
  • 32. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1). e7991. doi: 10.5812/hepatmon.7991. [PubMed: 23550108]. [PubMed Central: PMC3582303].
  • 33. Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, et al. [Distribution of hepatitis C virus genotypes in Jeju Island]. Korean J Hepatol. 2008;14(1):28-35. doi: 10.3350/kjhep.2008.14.1.28. [PubMed: 18367855].
  • 34. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006;78(5):569-73. doi: 10.1002/jmv.20577. [PubMed: 16555284].
  • 35. Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, et al. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Arch Virol. 2012;157(10):1959-65. doi: 10.1007/s00705-012-1369-9. [PubMed: 22695769].
  • 36. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007;13(2):156-63. doi: 10.1111/j.1365-2516.2006.01415.x. [PubMed: 17286768].
  • 37. Micalessi MI, Gerard C, Ameye L, Plasschaert S, Brochier B, Vranckx R. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005. J Med Virol. 2008;80(4):640-5. doi: 10.1002/jmv.21145. [PubMed: 18297717].
  • 38. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, Croce L, et al. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol. 2002;68(3):352-6. doi: 10.1002/jmv.10210. [PubMed: 12226821].
  • 39. Sharara AI, Ramia S, Ramlawi F, Fares JE, Klayme S, Naman R. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect. 2007;135(3):427-32. doi: 10.1017/S0950268806006911. [PubMed: 16848924]. [PubMed Central: PMC2870582].
  • 40. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004;74(2):246-52. doi: 10.1002/jmv.20170. [PubMed: 15332273].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments